ArticleRetina (Philadelphia, Pa.)2026
INFLUENCE OF THE BASELINE MORPHOLOGIC STAGE ON POSTOPERATIVE VISUAL ACUITY AND METAMORPHOPSIA OUTCOMES IN FOVEA-OFF RHEGMATOGENOUS RETINAL DETACHMENT.
Article in Retina (Philadelphia, Pa.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purposeTo evaluate the association between the baseline morphologic stage of rhegmatogenous retinal detachment and postoperative visual acuity and metamorphopsia.
methodsThis retrospective study included 39 consecutive patients with primary fovea-off rhegmatogenous retinal detachment who underwent scleral buckling at the Eye and ENT Hospital of Fudan University between 2018 and 2023. Optical coherence tomography, best-corrected visual acuity, and M-CHARTS were assessed at baseline and at 1, 3, 6, and 12 months postoperatively.
resultsBaseline morphologic Stage was 1 and 2 in 41%, 3 in 21%, 4 in 15%, and 5 in 23% of patients. Advanced morphologic stage was associated with worse best-corrected visual acuity ( P = 0.001, 0.001, 0.008, 0.002, and 0.002) and greater M-CHARTS scores ( P = 0.033, 0.004, 0.001, 0.003, and 0.005) at baseline and at 1, 3, 6, and 12 months postoperatively, respectively. After adjusting for covariates, the partial correlation coefficients between best-corrected visual acuity at baseline and at 1, 3, 6, and 12 months postoperatively were significantly positive ( P = 0.001, 0.001, 0.002, and 0.005, respectively), as were the partial correlation coefficients between preoperative vertical M-CHARTS scores and scores at 1, 3, 6, and 12 months postoperatively ( P < 0.001, 0.001, 0.001, and 0.027, respectively). The M-CHART scores at 3, 6, and 12 months were significantly better in Stages 1, 2, and 3 versus Stage 4 ( P = 0.002, 0.003, and 0.002, respectively).
conclusionPostoperative best-corrected visual acuity and metamorphopsia deteriorated significantly at all timepoints in patients with more advanced baseline morphologic stages, highlighting the need for earlier intervention in fovea-off rhegmatogenous retinal detachment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.